Munich, Germany – July 24, 2017 - EXTEDO, a leading provider of Regulatory Information Management solutions, announced its plans to open a new office in Shanghai, China, following major growth and success in the region. In addition to the new Shanghai office, EXTEDO already has offices in Germany, the UK, and the US.

With six reseller and consulting partners already within the region, including two in China, EXTEDO already has a strong presence in the Asian market. The introduction of the electronic Common Document Format (eCTD) for submissions planned for 2018 will broaden the need for local expertise and technology solutions. Through an established regional team, EXTEDO intends to build on this position.

“Over the past nine months, EXTEDO has successfully acquired 30 new customers within the Chinese market. This adds to us over 700 customers worldwide”, said Martin Schmid, Managing Director, EXTEDO. “With the planned introduction of eCTD in China in 2018, we see a significant opportunity to support the region through the EXTEDOsuite and our 20 years of industry knowledge. Our new Shanghai office will become the center of excellence for the region.”


EXTEDO was founded in 1996 as a department of IABG with a simple vision: to help life sciences organizations ensure Effortless Compliance with industry standards and regulatory requirements. EXTEDO is the only vendor that provides solutions covering the entire regulatory landscape. The EXTEDOsuite combines innovation with compliance and quality with usability. From Product Registration Planning & Tracking to Submission Publishing & Lifecycle Management to Pharmacovigilance Management and Document Management, EXTEDO optimizes eRegulatory business processes.

Today, EXTEDO enables more than 35 regulatory authorities, and over 700 maintained customers across 60 countries to deliver Effortless Compliance. Our clients range from small CROs to large multinational pharmaceutical organizations.


Latest Blog Posts


Interview: Meet EXTEDO’s eCTDtemplates!


Singapore's Transition to eCTD


Bertelsmann Investments Announces Another Major Investment in the Growing Pharma Tech Market


Interview: Meet EXTEDO’s Regulatory Intelligence (RI) Module!